Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a complex pathophysiology. According to WHO Atlas of MS 2013 estimated a prevalence rate of 5-20 per 100,000 population. The number has raised drastically in India in recent years. Estimates range from between 100,000 and 200,000 such patients throughout the country and worldwide it is 3 million.
Although Multiple Sclerosis (MS) is difficult to cure in early stages it can be cured. It becomes incurable after myelin is lost or damaged completely, but possible to manage. Early treatment approach with our special protocol can reverse the pathology. Depending on the person it can be cured or managed effectively. It is always advisable to start with the protocol within the first two years to achieve best results in primary progressive and progressive relapsing sub-types treatment.
